NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
NU SKIN ENTERPRISES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$4.97−0.17 (-3.31%)
Close on Oct 19, 2026
- Market cap
- $241.52M
- P/E (TTM)
- –
- Dividend yield
- –
NU SKIN ENTERPRISES, INC. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas [Member] | $59.76M | $57.82M | $76.98M | $63.99M | $72.95M | $69.06M | $85.36M | $77.19M | $84.94M | $75.03M | $97.75M | $91.67M | 18.7% | -18.1% |
| Manufacturing [Member] | $46.37M | $44.93M | $42.45M | $47.65M | $60.40M | $55.29M | $47.88M | $51.77M | $51.47M | $50.30M | $50.36M | $49.71M | 14.5% | -23.2% |
| Mainland China [Member] | $45.96M | $45.15M | $52.04M | $42.52M | $53.22M | $47.78M | $56.44M | $53.02M | $64.71M | $61.07M | $71.52M | $70.23M | 14.4% | -13.7% |
| Southeast Asia/Pacific [Member] | $43.26M | $45.47M | $50.51M | $56.29M | $50.83M | $52.17M | $64.93M | $59.52M | $60.34M | $60.07M | $66.89M | $68.74M | 13.5% | -14.9% |
| Japan [Member] | $38.14M | $39.74M | $42.50M | $44.55M | $44.55M | $42.77M | $47.51M | $47.22M | $42.59M | $44.24M | $50.97M | $53.40M | 11.9% | -14.4% |
| Europe & Africa [Member] | $32.32M | $31.22M | $41.80M | $38.00M | $37.33M | $33.02M | $42.60M | $38.58M | $40.71M | $42.27M | $47.89M | $50.05M | 10.1% | -13.4% |
| Hong Kong/Taiwan [Member] | $26.07M | $27.46M | $29.61M | $31.80M | $27.53M | $28.45M | $32.55M | $33.75M | $33.85M | $30.47M | $41.21M | $40.72M | 8.1% | -5.3% |
| South Korea [Member] | $25.62M | $25.33M | $28.43M | $35.20M | $34.07M | $32.52M | $33.42M | $45.20M | $44.12M | $40.96M | $48.38M | $63.71M | 8.0% | -24.8% |
| Rhyz Other [Member] | $2.53M | $3.73M | $6.07M | $3.97M | $4.83M | $2.92M | $35.22M | $21.38M | $16.36M | $12.23M | $14.74M | $10.81M | 0.8% | -47.6% |
| Nu Skin [Member] | – | – | – | – | – | – | – | – | – | – | – | $438.25M | – | – |
| Rhyz Investments [Member] | – | – | – | – | – | – | – | – | – | – | – | $60.53M | – | – |
| Rhyz [Member] | – | – | – | – | – | – | – | $73.15M | $67.83M | $62.53M | $65.10M | $60.53M | – | – |
| Nu Skin [Member] | – | – | – | – | – | – | – | $357.00M | $371.25M | $354.77M | $423.54M | $438.25M | – | – |
| Other [Member] | – | – | – | – | – | – | – | $2.52M | -$4.00K | $672.00K | – | -$274.00K | – | – |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mainland China [Member] | $11.34M | $9.82M | $13.99M | $6.56M | $14.46M | $10.55M | $13.19M | $7.28M | $13.37M | $12.25M | $14.07M | $15.22M | -21.6% |
| Americas [Member] | $11.14M | $11.00M | $14.52M | $13.40M | $16.82M | $15.75M | $19.48M | $15.88M | $17.38M | $14.98M | $17.21M | $16.63M | -33.7% |
| Japan [Member] | $10.93M | $11.36M | $11.93M | $13.24M | $11.95M | $11.85M | $13.60M | $13.49M | $11.70M | $12.01M | $14.04M | $14.62M | -8.6% |
| Hong Kong/Taiwan [Member] | $7.87M | $8.65M | $9.12M | $10.03M | $8.33M | $9.69M | $9.68M | $9.23M | $8.41M | $7.37M | $12.45M | $10.15M | -5.5% |
| Southeast Asia/Pacific [Member] | $7.66M | $9.30M | $9.56M | $12.84M | $12.22M | $12.15M | $13.44M | $10.00M | $10.71M | $11.08M | $10.69M | $13.19M | -37.3% |
| South Korea [Member] | $7.48M | $7.28M | $7.51M | $9.12M | $10.08M | $10.75M | $10.96M | $14.28M | $13.32M | $12.18M | $13.69M | $19.43M | -25.7% |
| Europe & Africa [Member] | $4.59M | $3.75M | $6.22M | $5.84M | $5.92M | $4.66M | $7.14M | $5.19M | $5.41M | $3.28M | $3.45M | $6.56M | -22.5% |
| Rhyz Other [Member] | -$447.00K | -$7.71M | -$26.80M | -$1.28M | -$137.00K | -$2.38M | -$31.47M | -$2.92M | -$5.47M | -$5.94M | -$9.25M | -$5.97M | +226.3% |
| Manufacturing [Member] | -$577.00K | -$82.00K | -$265.00K | $2.60M | $3.70M | $1.78M | -$2.81M | $542.00K | $1.76M | $1.97M | $4.64M | $4.84M | -115.6% |
| Nu Skin [Member] | – | – | – | – | – | – | – | – | – | – | – | $95.80M | – |
| Rhyz Investments [Member] | – | – | – | – | – | – | – | – | – | – | – | -$1.13M | – |
| Rhyz [Member] | – | – | – | – | – | – | – | -$2.38M | -$3.72M | -$3.98M | -$4.61M | -$1.13M | – |
| Nu Skin [Member] | – | – | – | – | – | – | – | $75.35M | $80.30M | $73.15M | $85.60M | $95.80M | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Nu Skin Enterprises's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.